MDT (Medtronic) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDT Medtronic PLC MDT
84 GF Score
Price $92.13
GF Value $100.67
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medtronic  (NYSE:MDT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medtronic Cyclically Adjusted PS Ratio Related Terms


Medtronic Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted PS Ratio Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.73 3.77 3.19 3.26 2.98

Medtronic Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.40 3.39 3.86 2.94 3.08

MDT vs SYK, BSX, EW: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PS Ratio falls into.


MDT
84GF Score
Medtronic PLC MDT
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Jul. 2026 is calculated as:

For example, Medtronic's adjusted Revenue per Share data for the three months ended in Jul. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jul. 2026 (Change)*Current CPI (Jul. 2026)
=7.592/128.7900*128.7900
=7.592

Current CPI (Jul. 2026) = 128.7900.

Medtronic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201610 5.275 99.776 6.809
201701 5.266 99.178 6.838
201704 5.734 100.773 7.328
201707 5.372 100.673 6.872
201710 5.162 100.374 6.623
201801 5.442 99.377 7.053
201804 5.962 100.374 7.650
201807 5.408 101.470 6.864
201810 5.497 101.271 6.991
201901 5.578 100.075 7.179
201904 6.031 102.068 7.610
201907 5.543 101.969 7.001
201910 5.702 101.969 7.202
202001 5.710 101.371 7.254
202004 4.445 101.969 5.614
202007 4.820 101.570 6.112
202010 5.656 100.474 7.250
202101 5.734 101.171 7.299
202104 6.028 103.065 7.533
202107 5.888 103.763 7.308
202110 5.790 105.557 7.064
202201 5.749 106.255 6.968
202204 6.015 110.242 7.027
202207 5.523 113.262 6.280
202210 5.694 115.315 6.359
202301 5.801 114.470 6.527
202304 6.411 118.213 6.985
202307 5.774 119.903 6.202
202310 5.994 121.111 6.374
202401 6.074 119.179 6.564
202404 6.480 121.232 6.884
202407 6.105 122.560 6.415
202410 6.530 121.956 6.896
202501 6.447 121.473 6.835
202504 6.933 123.888 7.207
202507 6.665 124.613 6.888
202510 6.957 125.410 7.145
202601 6.993 124.690 7.223
202604 7.613 128.430 7.634
202607 7.592 128.790 7.592

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medtronic (MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of $92.13 is trading 8.5% below its estimated GF Value™ of $100.67. GuruFocus considers Medtronic to be Fairly Valued.

Key valuation signals for MDT:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $100.67 vs. price of $92.13 (8.5% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
84GF Score

Get the complete analysis for MDT

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$92.13
Price
$100.67
GF Value